Company / Current Assets per Share
Ernexa Therapeutics Inc. Current Assets per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.91
FY2025
5-year range
$0.43 / $2.11
FY2021-FY2025
Trend
+110.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has fluctuated over the past 10 years, ranging from $0.10 in FY2015 to $5.77 in FY2016.
Based on SEC 10-K filings.
0.91 in FY2025 with a 10-year CAGR of +24.9%.
Declined from $1.87 to $0.91 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +9.0%
- 10-Year CAGR
- +24.9%
Key checks
Key Insights
- In FY2025, current assets per share increased 110.3% year-over-year.
- Peak current assets per share was recorded in FY2016.
- Lowest current assets per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.91 | +110.3% |
| FY2024 | $0.43 | -76.8% |
| FY2023 | $1.87 | +215.0% |
| FY2020 | $0.59 | -71.9% |
| FY2019 | $2.11 | -21.6% |
| FY2018 | $2.69 | +2481.3% |
| FY2017 | $0.10 | -98.2% |
| FY2016 | $5.77 | +5746.7% |
| FY2015 | $0.10 | -47.8% |
| FY2014 | $0.19 | +69.9% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026